DK150088D0 - Morpholinderivater, fremgangsmaade til deres fremstilling og farmaceutiske midler indeholdende dem - Google Patents

Morpholinderivater, fremgangsmaade til deres fremstilling og farmaceutiske midler indeholdende dem

Info

Publication number
DK150088D0
DK150088D0 DK150088A DK150088A DK150088D0 DK 150088 D0 DK150088 D0 DK 150088D0 DK 150088 A DK150088 A DK 150088A DK 150088 A DK150088 A DK 150088A DK 150088 D0 DK150088 D0 DK 150088D0
Authority
DK
Denmark
Prior art keywords
procedures
preparation
pharmaceutical agents
agents containing
morpholine derivatives
Prior art date
Application number
DK150088A
Other languages
English (en)
Other versions
DK171580B1 (da
DK150088A (da
Inventor
Gilbert Regnier
Claude Guillonneau
Jean Lepagnol
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of DK150088D0 publication Critical patent/DK150088D0/da
Publication of DK150088A publication Critical patent/DK150088A/da
Application granted granted Critical
Publication of DK171580B1 publication Critical patent/DK171580B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Control For Baths (AREA)
  • Earth Drilling (AREA)
DK150088A 1987-03-24 1988-03-18 Morpholinderivater, fremgangsmåde til deres fremstilling og farmaceutiske midler indeholdende dem DK171580B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8704047A FR2612926B1 (fr) 1987-03-24 1987-03-24 Nouveaux derives de la morpholine, leur procede de preparation et les compositions pharmaceutiques les renfermant
FR8704047 1987-03-24

Publications (3)

Publication Number Publication Date
DK150088D0 true DK150088D0 (da) 1988-03-18
DK150088A DK150088A (da) 1988-09-25
DK171580B1 DK171580B1 (da) 1997-02-03

Family

ID=9349348

Family Applications (1)

Application Number Title Priority Date Filing Date
DK150088A DK171580B1 (da) 1987-03-24 1988-03-18 Morpholinderivater, fremgangsmåde til deres fremstilling og farmaceutiske midler indeholdende dem

Country Status (17)

Country Link
US (1) US4782054A (da)
EP (1) EP0286495B1 (da)
JP (1) JPH0657709B2 (da)
AT (1) ATE89281T1 (da)
AU (1) AU600209B2 (da)
CA (1) CA1313870C (da)
DE (1) DE3880874T2 (da)
DK (1) DK171580B1 (da)
ES (1) ES2006390A6 (da)
FR (1) FR2612926B1 (da)
GR (1) GR1000241B (da)
HK (1) HK57297A (da)
IE (1) IE61882B1 (da)
NZ (1) NZ223984A (da)
OA (1) OA08822A (da)
PT (1) PT87061B (da)
ZA (1) ZA882107B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2653999A1 (fr) * 1989-11-06 1991-05-10 Adir Nouveaux derives de la morpholine, leur procede de preparation et les compositions pharmaceutiques les renfermant.
US5637699A (en) * 1992-06-29 1997-06-10 Merck & Co., Inc. Process for preparing morpholine tachykinin receptor antagonists
US5719147A (en) * 1992-06-29 1998-02-17 Merck & Co., Inc. Morpholine and thiomorpholine tachykinin receptor antagonists
US6048859A (en) * 1992-06-29 2000-04-11 Merck & Co., Inc. Morpholine and thiomorpholine tachykinin receptor antagonists
TW385308B (en) * 1994-03-04 2000-03-21 Merck & Co Inc Prodrugs of morpholine tachykinin receptor antagonists
AU2005238296A1 (en) * 2004-04-30 2005-11-10 Warner-Lambert Company Llc Substituted morpholine compounds for the treatment of central nervous system disorders
GB0409744D0 (en) * 2004-04-30 2004-06-09 Pfizer Ltd Novel compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1138405A (en) * 1966-12-28 1969-01-01 Ici Ltd Morpholine derivatives
BE758766A (fr) * 1969-11-17 1971-05-10 Ici Ltd Nouveaux derives de la morpholine et de la

Also Published As

Publication number Publication date
CA1313870C (fr) 1993-02-23
ZA882107B (en) 1989-06-28
NZ223984A (en) 1990-05-28
DE3880874D1 (de) 1993-06-17
PT87061B (pt) 1992-07-31
FR2612926B1 (fr) 1989-06-09
JPS63255279A (ja) 1988-10-21
PT87061A (pt) 1988-04-01
DE3880874T2 (de) 1993-12-23
IE61882B1 (en) 1994-11-30
AU600209B2 (en) 1990-08-02
AU1352088A (en) 1988-09-22
HK57297A (en) 1997-05-09
EP0286495B1 (fr) 1993-05-12
GR880100179A (en) 1989-01-31
ATE89281T1 (de) 1993-05-15
US4782054A (en) 1988-11-01
IE880851L (en) 1988-09-24
ES2006390A6 (es) 1989-04-16
EP0286495A1 (fr) 1988-10-12
DK171580B1 (da) 1997-02-03
OA08822A (fr) 1989-03-31
JPH0657709B2 (ja) 1994-08-03
FR2612926A1 (fr) 1988-09-30
GR1000241B (el) 1992-05-12
DK150088A (da) 1988-09-25

Similar Documents

Publication Publication Date Title
NO162467C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazo (1,5)-pyridiner og deres dihydro- og tetrahydroderivater.
NO992524L (no) Konsenserte bicykliske pyrimidin-derivater
DK150088D0 (da) Morpholinderivater, fremgangsmaade til deres fremstilling og farmaceutiske midler indeholdende dem
SE7703083L (sv) Forfarande for framstellning av piperidinderivat
AU534470B2 (en) Paromomycin derivatives
DK119188A (da) Substituerede pyridin-2,4-dicarboxylsyrederivater, fremgangsmaader til deres fremstilling samt laegemiddel indeholdende forbindelserne
NO932722L (no) Salter av et 4-amino-3acyl-kinolinderivat og deres anvendelse som inhibatorer for gastrisk syresekresjon
DK279988D0 (da) Spiro(4,5)decanderivater, fremgangsmaade til deres fremstilling og farmaceutiske midler indeholdende dem
HUT46214A (en) Process for producing medical preparation suitable for treatment of peptic ulcer
DK0427605T3 (da) Hidtil ukendte morfolinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
DK222588D0 (da) 5-quinoxalyl-imidazolidin-2,4-dioner, deres fremstilling og anvendelse som laegemidler
DK47988D0 (da) Substituerede 3-phenyl-7h-thiazolooe3,2-baaoe1,2,4aatriazin-7-oner, deres fremstilling og anvendelse som laegemiddel, samt ved fremstillingen anvendelige mellemprodukter
NO865347L (no) Fremgangsmaate for fremstilling av pyrimido (5,4-b)(1,4)oxazinderivater.

Legal Events

Date Code Title Description
PBP Patent lapsed